Bristol-Myers Squibb to Present at William Blair Conference, Cancer Immunotherapy: A Long-Awaited Reality

NEW YORK–(BUSINESS WIRE)– Bristol-Myers
Squibb Company (NYSE:BMY) will present at the William Blair
Conference, Cancer Immunotherapy: A Long-Awaited Reality, on Thursday,
March 31, 2016, in New York. Carl Decicco, senior vice president,
Discovery, will make a formal presentation at 8:05 a.m. EDT.

Materials related to the presentation will be available at http://investor.bms.com
at the start of the live webcast. An archived edition of the
presentation will be available later that day.

About Bristol-Myers Squibb

Bristol-Myers Squibb is a global biopharmaceutical company whose mission
is to discover, develop and deliver innovative medicines that help
patients prevail over serious diseases. For more information about
Bristol-Myers Squibb, visit us at BMS.com
or follow us on LinkedIn,
Twitter,
and YouTube.

View source version on businesswire.com: http://www.businesswire.com/news/home/20160324006103/en/